Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Kratz

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Metal-Based Drugs|January 1, 1996
The Interaction of the Antitumor Complexes Na[trans-RuCl(4) (DMSO)(Im)] and Na[trans-RuCl(4)(DMSO)(Ind)] With Apotransferrin: a Spectroscopic StudyL Messori, F Kratz, E Alessio
Metal-Based Drugs|May 14, 2008
Development of Acid-Sensitive Platinum(II) Complexes With Protein-Binding PropertiesM T Schütte, R Mülhaupt, F Kratz
Critical Reviews in Therapeutic Drug Carrier Systems|March 8, 2000
Drug-polymer conjugates containing acid-cleavable bondsF Kratz, U Beyer, M T Schütte
The Journal of Biological Chemistry|January 28, 1994
The binding properties of two antitumor ruthenium(III) complexes to apotransferrinF Kratz, M Hartmann, B Keppler, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 16, 2004
Reactivity of novel albumin-binding platinum complexesD Garmann, A Warnecke, F Kratz, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 19, 2003
Doxorubicin coupled to lactosaminated human albumin remains confined within mouse liver cells after the intracellular release from the carrierG Di Stefano, F Kratz, M Lanza, et al.
Human & Experimental Toxicology|March 6, 2007
Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicinF Kratz, G Ehling, H M Kauffmann, et al.
Journal of Medicinal Chemistry|February 7, 2001
A novel macromolecular prodrug concept exploiting endogenous serum albumin as a drug carrier for cancer chemotherapyF Kratz, R Müller-Driver, I Hofmann, et al.
Annals of the Rheumatic Diseases|April 15, 2008
Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritisC Fiehn, F Kratz, G Sass, et al.
Current Medicinal Chemistry|March 7, 2006
Prodrugs of anthracyclines in cancer chemotherapyF Kratz, A Warnecke, B Schmid, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Metal-Based Drugs|January 1, 1996
The Interaction of the Antitumor Complexes Na[trans-RuCl(4) (DMSO)(Im)] and Na[trans-RuCl(4)(DMSO)(Ind)] With Apotransferrin: a Spectroscopic StudyL Messori, F Kratz, E Alessio
Metal-Based Drugs|May 14, 2008
Development of Acid-Sensitive Platinum(II) Complexes With Protein-Binding PropertiesM T Schütte, R Mülhaupt, F Kratz
Critical Reviews in Therapeutic Drug Carrier Systems|March 8, 2000
Drug-polymer conjugates containing acid-cleavable bondsF Kratz, U Beyer, M T Schütte
The Journal of Biological Chemistry|January 28, 1994
The binding properties of two antitumor ruthenium(III) complexes to apotransferrinF Kratz, M Hartmann, B Keppler, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 16, 2004
Reactivity of novel albumin-binding platinum complexesD Garmann, A Warnecke, F Kratz, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 19, 2003
Doxorubicin coupled to lactosaminated human albumin remains confined within mouse liver cells after the intracellular release from the carrierG Di Stefano, F Kratz, M Lanza, et al.
Human & Experimental Toxicology|March 6, 2007
Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicinF Kratz, G Ehling, H M Kauffmann, et al.
Journal of Medicinal Chemistry|February 7, 2001
A novel macromolecular prodrug concept exploiting endogenous serum albumin as a drug carrier for cancer chemotherapyF Kratz, R Müller-Driver, I Hofmann, et al.
Annals of the Rheumatic Diseases|April 15, 2008
Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritisC Fiehn, F Kratz, G Sass, et al.
Current Medicinal Chemistry|March 7, 2006
Prodrugs of anthracyclines in cancer chemotherapyF Kratz, A Warnecke, B Schmid, et al.
Pageof 5